DELIGASE
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88855023
- Registration number
- 6412399
- Mark type
- Stylized text
- Filed
- 31 Mar 2020
- Published for opposition
- 04 Aug 2020
- Registered
- 06 Jul 2021
- Attorney of record
- Gazal Pour-Moezzi
Goods and services
- Class 042 — Scientific and technological services: Research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform
Owner
- Nurix Therapeutics, Inc., Brisbane, CA, US
- Nurix Therapeutics, Inc., San Francisco, CA, US
- Nurix Therapeutics, Inc., San Francisco, CA, US
Prosecution history
- 24 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Nov 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 May 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 May 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 May 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 18 Nov 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Nov 2020 — NON-FINAL ACTION E-MAILED
- 18 Nov 2020 — SU - NON-FINAL ACTION - WRITTEN